This study, published in the International Journal of Molecular Sciences, explores mesenchymal stem cells (MSCs) for treating systemic rheumatic diseases like lupus. It reviews the potential of MSCs due to their immunomodulatory properties and discusses challenges in clinical applications. The research outlines the promising results, especially for lupus, but also emphasizes the need for more research.
Menu
